BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21137461)

  • 1. [Innovations in locoregional treatments of breast cancer].
    Vlastos G; Monnier S; Vinh-Hung V
    Rev Med Suisse; 2010 Oct; 6(268):2016, 2018-23. PubMed ID: 21137461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Breast-conserving therapy in breast cancer].
    Marcollet A; Doridot V; Nos C
    Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy, axillary dissection and breast cancer: radiation oncologist's viewpoint.
    Bansal M; Mohanti BK
    Natl Med J India; 2002; 15(3):154-7. PubMed ID: 12186329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of sentinel node biopsy in the previously treated breast.
    Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
    Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for early-stage breast cancer after breast-conserving surgery.
    Buchholz TA
    N Engl J Med; 2009 Jan; 360(1):63-70. PubMed ID: 19118305
    [No Abstract]   [Full Text] [Related]  

  • 9. Sentinel node biopsy in elderly breast cancer patients.
    Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
    Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of sentinel node biopsy in breast cancer surgery].
    Stańczyk M; Dziekiewicz M; Maruszyński M; Olszewski WL
    Pol Merkur Lekarski; 2005 Aug; 19(110):245-8. PubMed ID: 16245445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cosmetic outcome of breast conserving therapy after sentinel node biopsy versus axillary lymph node dissection.
    Fabry HF; Zonderhuis BM; Meijer S; Berkhof J; Van Leeuwen PA; Van der Sijp JR
    Breast Cancer Res Treat; 2005 Jul; 92(2):157-62. PubMed ID: 15986125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surgical management of early breast cancer.
    Young AE
    Int J Clin Pract; 2001 Nov; 55(9):603-8. PubMed ID: 11770357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
    Cocilovo C; Boolbol SK; Valdes E; Feldman S
    Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation.
    Gray RJ; Forstner-Barthell AW; Pockaj BA; Schild SE; Halyard MY
    Am J Surg; 2004 Aug; 188(2):122-5. PubMed ID: 15249236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.